- Subject index
With escalating healthcare costs, changes to the regulatory control on pharmaceutical industries and the inevitable adjustments made in policies and investment in healthcare there is enormous interest in the commercial as well as the scientific aspects of today's healthcare industry.
The SAGE Handbook of Healthcare provides an authoritative analysis of the current (and anticipated) developments in the global healthcare industries. Providing a unique perspective that interfaces between the science and business aspects, it combines information on the latest scientific developments with applied, commercial business data from the global marketplace.
The Handbook focuses on the aspects of paramount importance in the healthcare sector: Pharmacoeconomics; Pharmacogenomics; Therapeutics; Diagnostics
Areas covered include: The role of nanotechnology, genomics and cell therapy in medicine; Diagnostics; Biomarkers and technological advances; Case studies in oncology ...
Chapter 11: Pharmaceutical Pricing, Reimbursement, and Prescribing in the United Kingdom
Pharmaceutical Pricing, Reimbursement, and Prescribing in the United Kingdom
In 1948, the United Kingdom established a pioneering universal healthcare system: the National Health Service (NHS). In the visionary words of its founders, the NHS was intended to offer all UK citizens comprehensive medical care “from the cradle to the grave.” The original concept was based on the principle that all healthcare provision -prescription medicines, primary care, dental and ophthalmic treatment, and hospitaliza-tion – should be free at the point of delivery. However, inexorably rising costs necessitated the progressive imposition of a range of patient copayments. In the 1960s, for example, the government introduced prescription charges in a bid to restrain the growth in NHS pharmaceutical expenditures. The ...